Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	220.45	340.24	234.21	249.77	150.48	187.24
Short-Term Investments	521.87	402.84	315.8	101.68	37.78	81.15
Cash & Short-Term Investments	742.32	743.08	550.01	351.45	188.26	268.39
Cash Growth	-2.35%	35.10%	56.50%	86.69%	-29.86%	96.77%
Prepaid Expenses	22.29	27.3	9.95	3.72	5.32	2.96
Total Current Assets	764.6	770.38	559.96	355.17	193.58	271.35
Property, Plant & Equipment	0.62	0.76	1.03	1.29	1.55	1.79
Long-Term Investments	343.93	54.75	19.28	-	-	-
Other Long-Term Assets	-	-	-	0.11	0.42	0.2
Total Assets	1,109	825.89	580.27	356.57	195.55	273.34
Accounts Payable	13.25	9.03	7.04	7.97	6.71	3.43
Accrued Expenses	32.5	30.1	11.57	10.79	18.22	9.39
Current Portion of Leases	0.37	0.29	0.52	0.33	0.21	0.29
Other Current Liabilities	0.78	0.34	-	-	-	-
Total Current Liabilities	60.4	39.75	19.13	19.08	25.13	13.11
Long-Term Debt	22.16	35.3	24.96	9.54	-	-
Long-Term Leases	0.37	0.53	0.82	1.08	1.31	1.52
Other Long-Term Liabilities	0.4	0.19	0.05	0.31	-	-
Total Liabilities	83.33	75.77	44.97	30.01	26.44	14.63
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,992	1,575	1,109	748.86	479.44	468.24
Retained Earnings	-967.39	-826.16	-574.1	-422.34	-310.3	-209.53
Comprehensive Income & Other	0.99	0.95	0.27	0.04	-0.03	-0
Total Common Equity	1,026	750.11	535.31	326.56	169.11	258.71
Shareholders' Equity	1,026	750.11	535.31	326.56	169.11	258.71
Total Liabilities & Equity	1,109	825.89	580.27	356.57	195.55	273.34
Total Debt	36.41	36.12	26.31	10.95	1.52	1.81
Net Cash (Debt)	1,050	761.71	542.99	340.5	186.74	266.58
Net Cash Growth	29.23%	40.28%	59.47%	82.34%	-29.95%	95.56%
Net Cash Per Share	13.98	11.35	10.33	8.73	5.36	8.47
Filing Date Shares Outstanding	79.99	79.62	56.3	46.97	35.01	34.77
Total Common Shares Outstanding	79.92	72.38	55.75	46.87	34.9	34.74
Working Capital	704.2	730.63	540.83	336.09	168.45	258.23
Book Value Per Share	12.84	10.36	9.60	6.97	4.85	7.45
Tangible Book Value	1,026	750.11	535.31	326.56	169.11	258.71
Tangible Book Value Per Share	12.84	10.36	9.60	6.97	4.85	7.45

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q